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Abstract 
Background: Temporins are small antimicrobial peptides secreted by the Rana temporaria showing mainly 
activity against Gram-positive bacteria. However, different members of the temporin family, as Temporin B, 
act in synergy also against Gram-negative bacteria. With the aim to develop a peptide with a wide spectrum 
of antimicrobial activity we designed and analyzed a series of Temporin B analogues. 
Methods: Peptides were initially obtained by Ala scanning on Temporin B sequence; antimicrobial activity 
tests allowed to identify the  TB_G6A sequence, which was further optimized by increasing the peptide 
positive charge (TB_KKG6A). Interactions of this active peptide with the LPS of E.coli were investigated by 
CD, fluorescence and NMR. 
Results: TB_KKG6A is active against Gram-positive and Gram-negative bacteria at low concentrations. The 
peptide strongly interacts with the LPS of Gram negative bacteria and folds upon interaction into a kinked 
helix. 
Conclusion: Our results show that it is possible to widen the activity spectrum of an antimicrobial peptide by 
subtle changes of the primary structure. TB_KKG6A, having a simple composition, broad spectrum of 
antimicrobial activity and a very low hemolytic activity, is a promising candidate for the design of novel 
antimicrobial peptides.  
General significance: The activity of antimicrobial peptides is strongly related to the ability of the peptide to 
interact and break the bacterial membrane. Our studies on TB_KKG6A indicate that efficient interactions 
with LPS can be achieved when the peptide is not perfectly amphipatic, since this feature seems to help the 
toroidal pores formation process.  
 
Highlights 
 A new Temporin B analogue, TB_KKG6A, was designed. 
TB_KKG6A is active against Gram-positive and Gram-negative bacteria. 
The peptide strongly interacts with the LPS of E.coli. 
The peptide folds into a kinked helix upon interaction with LPS. 
  The peptide shows very low hemolytic activity. 
  
 1. Introduction 
Antimicrobial peptides (AMPs) are a primitive component of innate immune system, that are 
constitutively or inducibly expressed in response to invasion by pathogens [1]. AMPs are widely 
distributed in nature, being produced by unicellular microorganisms, plants and animals, including 
humans. However, the amphibian integument is one of the most documented source of 
antimicrobial peptides, including bombinins, negrocins, brevinins, tigerinins, esculentins and 
temporins [2]. In response to a variety of stimuli, these chemicals are secreted onto the skin from 
granular glands found under the skin surface.  
AMPs have antimicrobial activity toward several different organisms such as Gram-negative and 
Gram-positive bacteria, viruses and fungi; moreover, some of them present antiparasitic activity and 
exhibit selective toxicity against cancer cells [3-5]. Because of these various pharmacological 
activities and of the growing multi-drug resistance of bacterial strains, AMPs have been raising 
considerable interest in medicinal chemistry as promising templates for the development of novel 
small therapeutic agents [6]. In addition, they are also recognized as a possible source of 
pharmaceuticals for the treatment of septic shock syndromes caused by the Gram negative bacteria 
lipopolysaccharide (LPS) [7, 8]. 
Studies performed in the presence of LPS have demonstrated that it actively regulates membrane 
insertion and antibacterial activities of many AMPs [9-12]. The initial attachment of AMPs to LPS 
might occur through ionic interactions leading to “self-promoted” peptide uptake via displacement 
of divalent cations [13, 14]; upon interaction, the peptides fold, intercalate the phospholipid bilayer 
and exert their antimicrobial activities [15]. 
Temporins are likely the most investigated among AMPs [16-18]. They were initially isolated from 
the skin of the European red frog Rana temporaria. They are 8–14 amino acids long, show a low 
net positive charge at neutral pH (ranging from 0 to +3) and are amidated at the C-terminus, as a 
result of a post-translational enzymatic reaction [19]. 
Temporins are particularly active against Gram-positive bacteria and are not toxic to eukaryotic 
cells. Since their cationic nature, they target the cytoplasmic membranes of microorganisms causing 
cell lysis [11, 20, 21]. The  lower antimicrobial activity of temporins against Gram-negative 
bacteria is due to the presence of the LPS on the outer membrane of these bacteria, which works as 
external barrier to the uptake of the peptides [22]. Temporin L (TL) and temporin-1DRa are the 
only members of the temporin family sharing a +3 charge that are active also against Gram-negative 
bacteria but possess a strong hemolytic activity [23, 24].Temporin-1a (TA) and 1b (TB) do not 
show activity against Gram-negative bacteria, probably because of a self-association occurring on 
LPS, but noteworthy, they become active when combined with a sub-inhibitory concentration of TL 
[16, 17, 25, 26]. Synergic effect  was observed for a synthetic TB analogue in combination with TA, 
leading to Gram-positive and Gram-negative anti-bacterial activity [25, 26]. 
Temporins, as most of the AMPs, are highly membrane-active and have been hypothesized to fold 
upon interaction with bacterial membranes. Temporins A and L, in fact, do not have conformational 
preferences in aqueous buffers while they assume the conformation of a  helix in model membrane 
systems such as SDS and DPC [27]. The peptide amphipathic helices have one hydrophobic face, 
supposed to be responsible for the insertion of the peptide in the lipid bilayer, and one hydrophilic 
face exposing the cationic residues which interacts with the negative charges of the lipids. Studies 
carried out on TL and TB in the presence of micelles and of negatively charged 
phosphatidylglycerol (PG) as membrane models lead to the hypothesis that the peptides intercalate 
the phospholipid bilayer forming oligomers, similar to amyloid fibers [15]. Recently, a NMR 
structural study of TL and TB in the presence of the LPS has also been reported [28], confirming 
the hypothesis of TL antiparallel dimerization. By contrast, independent TB has populations of 
helical and aggregated conformations in LPS [28]. 
Recent studies on TA analogues highlighted that hydrophobicity and positive charge determine the 
antimicrobial activity of the peptide [29]. 
In this study we designed a series of TB analogues with the aim to improve the peptide 
antimicrobial activity against both Gram-negative and Gram-positive strains and then to structurally 
elucidate the mechanism of interaction of active peptides with LPS. The peptides were synthesized 
substituting one or two amino acids with an alanine and lengthening the sequence with positively 
charged amino acids. Among the 16 designed peptides, TB_KKG6A, shows highly increased 
activity against Gram negative bacteria and also a slightly increased activity against Gram positive 
bacteria as compared to TB, with a very low hemolytic activity. Molecular details at the basis of the 
interaction of TB_KKG6A with the LPS from E. coli were investigated via Circular Dichroism 
(CD), Fluorescence and NMR.  
 
2. Materials and methods 
 
2.1 Materials 
The amino acids used for the peptide synthesis Fmoc-Ala-OH, Fmoc-Asn(Trt)-OH, Fmoc-Gly-OH, 
Fmoc-Ile-OH, Fmoc-Leu-OH, Fmoc-Lys(Boc)-OH, Fmoc-Pro-OH, Fmoc-Ser(OtBu)-OH, Fmoc-
Val-OH, Fmoc-Ahx-OH, the Rink amide MBHA resin and the activators N-Hydroxybenzotriazole 
(HOBT) and O-Benzotriazole-N,N,N’,N’-tetramethyl-uronium-hexafluoro-phosphate (HBTU) were 
purchasedfrom Novabiochem (Gibbstown, NJ, USA). Acetonitrile (ACN) was from Reidel-deHaën 
(Seelze, Germany) and dry N,N-dimethylformamide (DMF) from LabScan (Dublin, Ireland). All 
other reagents were from Sigma Aldrich (Milan, Italy). LC-MS analyses were performed on a LC-
MS Thermo Finnigan with an electrospray source (MSQ) on a Phenomenex Jupiter 5μ C18 300Å, 
(150x4.6 mm) column. Purification was carried out on a Phenomenex Jupiter 10Proteo 90Å 
(250x10mm) column. LPS of E. coli 0111:B4 was purchased from Sigma Aldrich.  
 
2.2 Peptide synthesis 
Peptides were synthesised on solid phase by Fmoc chemistry on the MBHA (0.54 mmol/g) resin by 
consecutive deprotection, coupling and capping cycles. Deprotection : 30% piperidine in DMF, 5 
minutes (2x). Coupling: 2.5 equivalents of amino acid + 2.49 equivalent of HOBT/HBTU (0.45 M 
in DMF) + 3.5 equivalents NMM, 40 minutes. Capping: acetic anhydride/DIPEA/DMF 15/15/70 
v/v/v, 5 minutes.  
Peptides were cleaved off the resin and deprotected by treatment of the resin with a solution of 
TFA/TIS/H2O 95/2.5/2.5 v/v/v, 90 minutes. TFA was concentrated and peptides were precipitated 
in cold ethylic ether. Analysis of the crudes was performed by LC-MS using a gradient of 
acetonitrile (0.1% TFA) in water (0.1% TFA) from 5 to 50% in 30 minutes. Purifications were 
performed by semipreparative RP-HPLC using a gradient of acetonitrile (0.1% TFA) in water 
(0.1% TFA) from 5 to 50% in 30 minutes. (See Supplementary information-Table S1 for mass spec 
results). 
  
 
 
 
2.3 NBD conjugation 
To the resin bound peptide the Fmoc-Ahx-OH linker was coupled and Fmoc deprotected following 
standard procedures for peptide synthesis. NBD-Cl (5 eq.) was dissolved in DMF, NMM (7 eq) was 
added; the solution was reacted with the peptide 3 hours at r.t. and double couplings were 
performed. 
Peptides were cleaved off the resin and deprotected by treatment of the resin with a solution of 
TFA/TIS/H2O 95/2.5/2.5 v/v/v, 90 minutes. TFA was concentrated and peptides were precipitated 
in cold ethylic ether. Analysis of the crudes was performed by LC-MS using a gradient of 
acetonitrile (0.1% TFA) in water (0.1% TFA) from 30 to 70% in 30 minutes. Purification was 
performed by semipreparative RP-HPLC using a gradient of acetonitrile (0.1% TFA) in water 
(0.1% TFA) from 30 to 70% in 30 minutes. 
 
2.4 Circular dichroism 
Circular dichroism (CD) spectra were recorded at 25° C using a 1 cm quartz cell with the Jasco-810 
spectropolarimeter using a 260 – 195 nm measurement range, 100 nm/min scanning speed, 1 nm 
bandwidth, 4 sec response time, 0.5 nm data pitch. 
Peptides concentration for CD measurement was 5 μM. CD spectra were registered in 10 mM 
sodium phosphate buffer, pH 7.4 and in 10 mM  sodium phosphate, 20 mM SDS buffer pH 7.4.  
LPS titrations were carried out recording the CD spectra of the peptide TB_KKG6A in the presence 
of increasing concentrations of LPS at 25°C, up to a molar ratio LPS/peptide 2:1.The peptide was 
dissolved in Phosphate buffer 10 mM pH 7 at a 5 M concentration; the LPS was dissolved in 
Phosphate buffer 10 mM pH 7 at a 50 M concentration, before use it was subjected  to  
temperature cycles between 4° and 70°C, interrupted by vortexing (10 minutes). The sample was 
stored at 4°C  overnight. 
 
2.5 Fluorescence Studies  
LPS titrations were carried out monitoring the fluorescence intensity at 530 nm of the peptide 
TB_KKG6A-NBD in the presence of increasing concentrations of LPS, up to a 2:1 LPS/ peptide 
molar ratio. The excitation wavelength was set at 487 nm. The peptide was dissolved in Phosphate 
buffer 10 mM pH 7 at a 0.5 M concentration, the LPS was dissolved in Phosphate buffer 10 mM 
pH 7 at a 5 M concentration. All experiments were repeated in duplicate. 
 
2.6 ITC studies 
Calorimetric studies were carried out on a Microcal ITC200 GE instrument. LPS was dissolved in 
degassed 50mM Phosphate buffer pH 6.8, subjected  to  temperature cycles between 4° and 70°C, 
interrupted by vortexing (10 minutes) [30]. The sample was stored at 4°C overnight. The titration 
sequence involved 30 injections at 4 minutes intervals of 1 L aliquots of TB_KKG6A (2mM) 
dissolved in Phosphate buffer 50 mM pH 6.8 into the sample cell filled with 280 L of LPS 50 M 
in Phosphate buffer 50 mM pH 6.8 at  37°C and 350 rpm. The experiment was carried out in 
triplicate. 
 
 
2.7 Bacteria 
The study included the following species: Staphylococcus aureus (isolate A170), Staphylococcus 
epidermidis, Salmonella typhimurium (S. typhimurium), Escherichia coli. Isolates were obtained 
from patients hospitalized at the Medical School of the University of Naples. Specimen were 
confirmed by PCR assay of the genes sea (S. aureus), fliC (S. typhimurium), sat (E. coli), ureD S. 
Epidermidis [31-33]. 
 
2.8 Antibacterial activity  
Bacteria were grown at 37°C in TSB (S. aureus and S. epidermidis) or in LB medium (the 
remaining bacterial species), harvested while in exponential phase (OD600 nm; 0-6-0.8), 
centrifuged (8x10
3
 g for 10 min), washed with saline (0.15 M NaCl), resuspended in Muller Hinton 
(MH) broth at the concentration of approximately 2x10
6
 CFU/mL and distributed, in triplicate, into 
96 well plates (60 L/well), mixed with increasing concentrations of the antimicrobial peptides 
dissolved in sterile distilled water (5–400 g/mL, 40 L/well) and incubated at 37°C for 20 h. The 
minimal peptide concentration at which 100% inhibition of microbial growth was observed, is 
defined as MIC and determined by measuring the absorbance at 540 nm (Biorad microplate reader 
model 680, Hercules, CA). 
2.9 Test of the hemolytic activity of the antimicrobials 
TB_KKG6A was tested for its hemolytic activity using mouse red blood cells. The blood was 
collected from the tail of the animals, centrifuged (4x10
2
 g for 3 min) and washed with saline. A 4% 
suspension of mouse red blood cells was mixed with the peptide ( from 5 g/mL to 45 g/mL) and 
incubated for 1 h at 37°C. The hemolytic activity was measured according to the formula (OD peptide 
- OD negative control)/(OD positivecontrol - OD negative control ) x100 where the negative control (0% 
haemolysis) is represented by erythrocytes suspended in saline and the positive control (100% 
haemolysis) is represented by the erythrocytes lysed with 1% triton X100 [34]. 
 
2.10 NMR Spectroscopy 
The samples for NMR spectroscopy were prepared by dissolving the appropriate amount of peptide 
in 0.50 mL of 
1
H2O, 0.05 mL of 
2
H2O.  
The NMR experiments were acquired at 298 K on a Varian Unity INOVA 500 MHz spectrometer at 
Dipartimento di Scienze Ambientali of Second University of Naples. 
NMR experiments were processed using Varian (VNMR 6.1B) software. 
1
H chemical shifts were 
calibrated using TMS. The program XEASY was used to analyze and assign the spectra. 
The interaction of TB_KKG6A peptide with LPS was examined by recording series of one 
dimensional proton NMR spectra whereby 0.5 mM of TB_KKG6A in aqueous solution, pH 4.5, 
was titrated with various concentrations, 0.08, 0.15, 0.2 and 0.6 mg/mL of E. coli LPS (Sigma-
Aldrich).  
The 2D tr-NOESY experiments for E. coli LPS-bound TB_KKG6A were recorded at the LPS 
concentration of 0.15 mg/mL, at 298 K, which generated a large number of tr-NOE cross peaks.  
The peptide/LPS complex was found to be stable over the period of data collection at these 
concentrations of LPS. The 2D tr-NOESY spectra were recorded at three different mixing times 
(150, 200 and 300 ms) with 512 increments in t1 and 2K data points in t2. The spectral width was 
normally 10 ppm for both dimensions. 
For saturation transfer difference (STD) experiments, TB_KKG6A (0.5 mM) was dissolved in 550 
L of H2O/D2O and pH was adjusted to 4.5. A stock solution (1 mM) of LPS from E. coli was 
prepared in H2O, at pH 4.5. STD experiments were performed at 298 K in the presence of 5 M 
LPS using standard STD pulse sequences [35]. One-dimensional STD experiments were carried out 
as described previously [36, 37]. Selective saturation of LPS resonances was achieved at -2.0 ppm 
(40 ppm for reference spectra) using a series of 40 Gaussian-shaped pulses (49 ms, 1 ms delay 
between pulses), for a total saturation time of 2s. Subtraction of the two spectra (on resonance - off 
resonance) by phase cycling [35] leads to the difference spectrum that contains signals arising from 
the saturation transfer.  
Paramagnetic relaxation experiments were performed by adding aliquots of 16-doxyl-stearic acid 
(16-DSA) (solubilized in deuterated methanol) or Mn
2+
 (dissolved in H2O), into the samples 
containing the peptide-LPS complex (0.5 mM TB_KKG6A and 0.13 mg/mL E. coli LPS). The 
samples were allowed to equilibrate for 20 min before performing 2D 
1
H-
1
H-TOCSY experiments. 
The intensities of cross-peaks of TB_KKG6A in the presence of LPS were measured before and 
after the addition of the paramagnetic probes so that the remaining amplitudes could be calculated.  
2.10 NMR derived structure calculation 
NMR structures were calculated using the CYANA program [38, 39]. The tr-NOE-based distance 
restraints were obtained from tr-NOESY spectrum recorded with a mixing time of 150 ms. The tr-
NOE cross peaks were integrated with the XEASY program and were translated to upper bound 
distances using the CALIBA program incorporated into the program package CYANA. Hydrogen 
bond constraints were not used during structure calculations. A total of 100 structures was 
calculated, and the 20 conformers with the lowest CYANA target function were employed for 
further analysis. The structures were visualized using the program MOLMOL [40]. The quality of 
the structures was determined using PROCHECK-NMR [41].  
 
3 Results 
3.1 Design of TB analogues and their antimicrobial activity 
Peptides belonging to the temporin family share the consensus sequence XXXXXXYXXY
+
YXX, 
where X=hydrophobic amino acid, Y=hydrophilic, Y
+
=positively charged, with leucine and 
isoleucine being the most abundant hydrophobic amino acids and lysine the positively charged 
amino acid most represented [42]. In order to evaluate the role of each amino acid side chain on the 
peptide activity, a complete Ala scanning of TB has been executed: a series of TB analogues was 
obtained by substituting one or two amino acids with alanine residues (Table S1). Their 
antimicrobial activities were tested against Gram-positive (S. aureus and S. epidermidis) and Gram-
negative (E. coli and S. typhimurium) bacteria. Functional tests indicated that TB_P3A, TB_N7A 
and TB_S11A preserve an antimicrobial activity comparable to TB; the other analogues lose 
completely their activity while, notably, TB_G6A exhibits an increased activity against Gram 
positive bacteria. (Table 1 and Table S2) Furthermore, as the positively charged amino acid is 
reported in many cases to be essential for the interaction between antimicrobial peptides and 
bacterial membranes, we investigated the role of the position of the positively charged side chain; in 
particular, we exchanged the amino acids in positions 1 and 10 (TB_L1K_K10L) to keep constant 
either the charge and the amino acid content [29]. This peptide shows antimicrobial activity against 
Gram positive bacteria only at high concentrations (50g/mL).  
Based on these data, mutations in position 6 were analyzed to further improve the peptide activity. 
The side chain steric hindrance in this position was modified by synthesizing  TB_G6V and 
TB_G6I. Their antimicrobial activities were tested and found lower than that of TB_G6A. For this 
reason TB_G6A was chosen for further optimization. The double mutant, TB_G6A_S11A, was 
analyzed to investigate the effect of widening the hydrophobic surface of the peptide; this peptide 
exhibits the same antimicrobial activity of TB_G6A.  
Finally, the effect of increasing the positive charge on the antimicrobial activity of TB_G6A was 
explored, designing the peptide TB_KKG6A, which presents 2 extra lysines at the N-terminus of 
TB_G6A. This peptide was designed based on previous observations suggesting that the presence of 
two lysines at the N-terminus of another TB analogue expanded its antimicrobial activity also to 
Gram negative bacteria [26].Interestingly, the analogue TB_KKG6A (+4 total charge) shows an 
expanded spectrum of activity as compared to TB, being active against Gram negative bacteria 
(5g/mL against E. coli and 10 g/mL against S. typhimurium) and Gram positive bacteria at low 
concentrations. Importantly, TB_KKG6A shows very low hemolytic activity (Figure S1). 
 
3.2 Conformational analysis of TB analogs by CD  
Peptide secondary structures were determined by CD spectroscopy. All the analogues obtained by 
alanine scanning show the same behavior. The conformation of the peptides in phosphate buffer at 
pH= 7.4 is predominantly disordered, whereas in SDS micelles at pH= 7.4 they predominantly show 
a helical conformation (Figure S2).  
TB_KKG6A CD spectra were recorded in the presence of SDS and E. coli LPS (Figure 1A). In 
SDS, TB_KKG6A is clearly in helical conformation. In the presence of E. coli LPS the peptide 
partly assumes a helical conformation.  
 
3.3 Binding studies of TB_KKG6A to LPS by Fluorescence and CD 
The interaction of TB_KKG6A with LPS was investigated by a combination of fluorescence, CD 
and ITC analysis. For the fluorescence experiments we employed the TB_KKG6A derivative 
conjugated to 7-nitrobenzo-2-oxa-1,3-diazole(NBD) (TB_KKG6A_NBD), a fluorescent probe 
which changes its emission in a hydrophobic environment. Fluorescence experiments carried out 
titrating the E. coli LPS into TB_KKG6A_NBD revealed a strong variation of the fluorescence 
intensity (Figure 2).The Kd of the peptide-E. coli LPS complex was found to be 47±6 nM. This 
value is in agreement with those obtained by fluorescence for other active antimicrobial peptides. 
[43] As binding of the peptide to LPS is concomitant to folding, we also calculated the binding 
constant plotting the CD molar ellipticity at 222 nm as a function of the LPS concentration and we 
obtained a similar Kd value (Figure S3).ITC experiments were carried out by titrating the peptide 
into the LPS at 37°C. In this conditions the binding is an exothermic process; due to inhomogeneity 
of the LPS samples it is not possible to determine  the binding constant of the peptide to LPS by 
ITC (Figure 3). 
 
3.4 NMR analysis of TB_KKG6A in aqueous solution and in presence of LPS  
Sequence specific resonance assignment of all TB_KKG6A amino acids was achieved analyzing 
1
H-
1
H TOCSY and 
1
H-
1
H NOESY spectra [44]. Chemical shifts have typical random coil values 
(Table S3). Accordingly, the NOESY spectra of the free peptide are predominantly characterized by 
intra-residue and sequential NOEs between backbone and side chain proton resonances (Figure S4), 
suggesting that TB_KKG6A is largely disordered in aqueous solution.  
Additions of E. coli LPS to TB_KKG6A solution result in concentration-dependent moderate line 
broadening of the proton resonances without significant changes in chemical shifts (Figure 1B), 
indicating the binding of TB_KKG6A to LPS  as confirmed by the fluorescence experiments 
(Figure 2). Accordingly, two-dimensional tr-NOESY spectra of TB_KKG6A obtained in the 
presence of sub-stoichiometric E. coli LPS show a significant number of NOE connectivities, 
suggesting a LPS-induced structural transition from a random coil state to a well-folded 
conformation of TB_KKG6A (Figure S5).  
Residues in segments Pro3–Asn7 and Leu9–Ser11 are characterized by strong HNi-HNi+1 NOEs and 
several medium range NOEs, such as HNi-HNi+2, Hi–HNi+3, and Hi -Hi+3 correlations, typical of 
a helical conformation (Figure S6A,B) [44]. Noteworthy, the absence of NOE contacts involving 
residues which are far apart in the molecular structure indicates that the peptide in the presence of 
LPS  very likely does not undergo self-association. 
A total of 171 NOEs was obtained from the tr-NOESY spectra; these NOEs resulted in 129 
meaningful distance constraints (103 inter-residues, 26 intra-residues) and 67 angle constraints 
which were used for the structure calculations. All the constraints (Table 2) were used to generate a 
total of 100 structures, among which the 20 with the lowest target function were selected and 
energy minimized. The obtained structures satisfied the NMR spectroscopic constraints, with no 
NOE violations greater than 0.2 Å. In Figure 4, the sausage representation of TB_KKG6A bound to 
E. coli LPS NMR ensemble of structures is shown. TB_KKG6A structure is well defined as the 
RMSD for residues Leu2-Leu12 is 0.34 Å.  
The peptide TB_KKG6A in the presence of E. coli LPS assumes mostly a helical conformation; in 
detail, a first helical segment encompassing residues Pro3 to Asn7, is followed by a kink including 
residue Leu8 and by a second helical region from residue Leu9 to Ser11. The angle between the two 
helix axes is about 100°. Interestingly, TB_KKG6A structure shows a certain degree of 
amphipathicity that characterizes mainly the central tract of the peptide (Figure 5).   
 
3.5 Structural characterization of TB_KKG6A-E. coli LPS interaction by STD  
A close proximity of TB_KKG6A with E. coli LPS was revealed from saturation transfer  
difference (STD) NMR studies [35]. In the STD spectrum of TB_KKG6A (Figure S7) all the side 
chain proton resonances were observed, indicating that the entire peptide is closely associated with 
LPS. Unambiguous STD effects were assigned to Pro3, Asn7 and Lys10 resonances. In particular, 
H3 of Pro3 and H of Asn7 show a moderate STD effect (25% and 35%) while a stronger STD 
effect is observed for H of Lys10 (63%) (Figure S8), suggesting a closer proximity of Lys10 and at 
a lesser extent of Pro3 and Asn7 to LPS.  
 
 
 
 
3.6 Topological Orientation of TB_KKG6A by NMR Paramagnetic Relaxation Enhancement 
(PRE) 
In order to determine the positioning of TB_KKG6Awith respect to the LPS, an internal 
paramagnetic mapping was carried out on the peptide-LPS solution. The 16-doxylstearic acid (16-
DSA) was used as internal probe. Its unpaired electrons lead to dramatically accelerated 
longitudinal and transverse relaxation rates of protons in spatial proximity via highly efficient spin 
and electron relaxation. Therefore, this paramagnetic probe was expected to cause a broadening of 
the NMR signals and a decrease in resonance intensities of the residues deeply buried in the (16-
DSA). [45, 46]Side chain resonances, mostly H protons of Pro3, Ala6, Asn7, Lys10, Leu12 and 
Leu13, are selectively reduced, indicating that these residues are closer to 16-DSA paramagnetic 
probe and likely penetrate the LPS through their side chains, defining a clear interaction surface 
(Figures 6 and Figure S8). Furthermore, the effect of 16-DSA was observed also for the H protons 
of Lys-1 and Lys10 that are differently affected by the paramagnetic probe and confirms that Lys-1 
side chain lies on the surface of the LPS, whereas Lys10 side chain is able to penetrate it. 
Interestingly, TB_KKG6A structure reveals that Lys10 side chain populates two different 
conformational families, one directed to the solvent bulk and the other embedded into the LPS 
(Figure 6). The larger perturbation ofLys10 Hs with respect to that of Hs reflects the 
conformational mobility of that side chain that does not involve Lys10 H protons but do comprise 
Lys10 Hprotons (Figure 6). These data are confirmed by the complementary paramagnetic effects 
observed in the presence Mn
2+
 ion (data not shown). 
 
 
 
  
4 Discussion and Conclusions 
Studies carried out on natural and rationally designed antimicrobial peptides highlighted the 
importance of the hydrophobicity and the positive charge in the determination of the structure and 
the antimicrobial activity of AMPs. As a matter of fact, these two factors play a key role in the 
peptide ability to properly interact with the outer membrane constituents of bacterial cells and to 
form pores within the membrane [47]. Interaction with the outer leaflet represents in most cases a 
crucial step to accomplish the peptide antimicrobial activity, although other mechanisms accounting 
for peptide antimicrobial activity have been proposed [43, 48]. Therefore, structural investigations 
of antimicrobial peptides in complex with LPS, a major component of the bacterial membranes, are 
essential to fully understand their mechanism of action [49, 50]. 
In this study TB analogues were designed to increase the peptide antimicrobial activity against both 
Gram negative and Gram positive strains and molecular details of the interaction between the active 
designed peptides and LPS were obtained at an atomic resolution.  
To better understand the role of each side chain on the peptide activity a complete Ala scanning of 
TB was executed. Functional tests indicated that TB_P3A,TB_G6A, TB_N7A and TB_S11A 
preserve antimicrobial activities against Gram.positive bacteria, whereas the other analogues 
completely lose their activity (Table 1). These results indicate that mutation in alanine is not 
detrimental to the peptide antimicrobial activity when the substituted side chain has a comparable or 
smaller dimension. This is an indication that the side chain dimensions play a clear role in the 
peptide functionality. Interestingly, replacement of glycine in position 6, leads to the most active 
peptide, TB_G6A, among the studied temporin analogues. On the other hand, introduction of larger 
hydrophobic amino acids in position 6 (TB_G6V and TB_G6I) revealed that further increase of side 
chain steric hindrance does not improve the recognition of the bacterial membrane.  
Lys10 plays a pivotal role for the antimicrobial activity of TB against Gram-positive bacteria, since 
it likely anchors the peptide to the membranes, interacting with the negatively charged 
phospholipids. Accordingly, the TB_K10L analogue is inactive, whereas the derivative 
TBK1L_L10K, in which the charge and composition are invariant with respect to TB, shows 
antimicrobial activity against Gram- positive bacteria only at high concentrations. 
All the peptides obtained by Ala scan are not active against Gram-negative bacteria such as S. 
typhimurium and E. coli. To further improve its antimicrobial activity, the most active TB_G6A 
was further modified adding two extra lysines at the N-terminus in order to verify the effect of 
increasing the positive charge of the peptide. The resulting peptide, TB_KKG6A (with a +4 
charge), has antimicrobial activity against Gram positive bacteria comparable to that of the other 
analogues, but interestingly, it also exhibits significant activity against Gram negative bacteria at 
low concentrations, without showing hemolytic activity. TB_KKG6A was therefore chosen for a 
detailed structural investigation. CD analyses revealed that the peptide contains a significant degree 
of helical conformation in the presence of E. coli LPS (Figure 1).High resolution structure of 
TB_KKG6A in the presence of E. coli LPS was determined by NMR. TB_KKG6A bound to LPS 
has a non-compact helical structure defined by two short helices, one spanning residues Pro3–Asn7 
and a much shorter one at the C-terminus that spans residues Leu9–Ser11 (Figure 4). 
TB_KKG6Astructure shows only partial amphipathicity, mostly confined to the central region of 
the peptide chain (Figure 5), which likely contributes to its non-hemolytic activity. Fluorescence, 
CD and 
1
H-NMR experiments, carried out by titrating E. coli LPS into TB_KKG6A, provided 
details at molecular level of the interaction between TB_KKG6A and the LPS, revealing a high 
affinity interaction of the peptide for this LPS. The binding of antimicrobial peptides to LPS is a 
very complicate process, which causes a reorganization of the LPS/lipid A structure from the 
original unilamellar/cubic into a multilamellar one; in some cases a transition of gel to liquid 
crystalline phase of the LPS, which also depends on the temperature, has been observed upon 
interaction of the endotoxin with antimicrobial peptides [51, 52]. In this study, through different 
techniques, in particular fluorescence by which we monitor the changes in the peptide environment 
due also to variation in the LPS structure, and CD by which we observe changes into the peptide 
secondary structure upon interaction with LPS, we obtained comparable values for the binding 
constant of the peptide to LPS (respectively 47±6 and 27±13 nM). These values are consistent with 
those of other active antimicrobial peptides obtained using fluorescence spectroscopy [25]. ITC 
experiments, carried out at 37°C, revealed that binding of the peptide to LPS is an exothermic 
process, driven by the electrostatic interactions between the positively charged peptide and the 
negatively charged LPS as observed for other antimicrobial peptides reported in the literature [51, 
53, 54]. 
Atomic resolution interaction and localization of TB_KKG6A on the surface of E. coli LPS were 
characterized by STD and PRE experiments, providing molecular insights into the mechanisms by 
which the peptide exerts its antimicrobial activity.  
In particular, our structural data describe TB_KKG6A conformational propensities required for the 
carpeting of the LPS outer leaflet. The extra Lys residues (Lys-1 and Lys-2) of TB_KKG6A lie on 
the external surface of the LPS, anchoring the peptide to the bacterial membranes by interacting 
with the negatively charged phospholipids [55] and likely contribute to prevent the peptide 
oligomerization. Furthermore, STD and DSA paramagnetic mapping data clearly indicate that Pro3, 
Ala6, Asn7, Leu12 and Leu13 side chains permeate the LPS, allowing Lys10 long and amphipathic 
side chain to penetrate the surface. The two conformations observed for the Lys10 side chain 
reasonably account for the initial absorption and the subsequent insertion of the peptide into the 
LPS. Interestingly, Gly to Ala substitution improves TB_KKG6A hydrophobicity at the peptide-
LPS interface which includes  also Pro3 and Asn7 that can be mutated to Ala without affecting TB 
antimicrobial activity (Table 1). Overall, TB_KKG6A-LPS interaction stabilizes two short helical 
structures having some degree of amphipathicity in the peptide central region. These structural 
features propose possible implication in TB_KKG6A pore formation capability. In particular, 
TB_KKG6A structure in E. Coli LPS is only partially helical, amphipathic and relatively short to 
span an unperturbed phospholipid bilayer, therefore suggesting the formation of disordered toroidal 
pores when the peptide is incorporated inside the bacterium membranes. Accordingly, Mihalovic 
and Lazaridis compared the pore formed by magainin and melittin and showed that the distribution 
of positive charges at the peptide N-terminus and imperfect amphipathicity appears to facilitate the 
formation of toroidal pores, attracting LPS head groups and pulling them into the pore[47]. 
Concomitantly, the presence of positively charged side chains in the middle of the peptide results in 
more disordered pores.  
It has been proposed that helicity of the AMPs is one of the key features for their hemolytic but not 
for their antimicrobial activity [56]. A strong hemolytic activity generally correlates with high 
hydrophobicity, high amphipathicity, and high helicity. In addition, a higher ability to self-associate 
in solution is generally correlated with weaker antimicrobial activity and stronger hemolytic activity 
of the antimicrobial peptides [56].In this frame the here reported monomeric and partially helical 
and amphipathic structure of TB_KKG6A appears to answer to the structural requirements 
necessary to increase the antimicrobial activity and reduce toxicity to eukaryotic cells.  
Interestingly the composition of the LPS is crucial for the recognition and folding processes by the 
peptide. In fact, CD experiments carried out for TB_KKG6A in the presence of S. typhimurium LPS 
variant with shorter sugar chains at distal region of the O-antigen moieties show that in this case the 
peptide has a low, although clearly visible, content of secondary structure (manuscript in 
preparation). 
In summary, the experiments described in this study have highlighted the possibility to widen the 
original spectrum of action of AMPs selective for Gram-positive bacteria to Gram-negative bacteria 
by appropriate changes in the peptide primary structure. By combining CD, NMR and fluorescence 
analyses we obtained a molecular-level resolution of the TB_KKG6A structure and of its 
interaction with E. coli LPS. Our finding show that TB_KKG6A, having a simple composition, 
broad spectrum of antimicrobial activity and no hemolytic activity, is a promising candidate for the 
design of novel antimicrobial peptides with improved antimicrobial activity and very low hemolytic 
effect.  
 
 
 
  
Figures 
 
Figure 1: A) CD spectra of TB_KKG6A (5 M) recorded in Phosphate buffer 10 mM pH 7.0 (blue 
curve), E. coli LPS, peptide/LPS 1:1 molar ratio (green line), B) Low-field region of one-
dimensional 
1
H NMR spectra of 0.5 mM TB_KKG6A in aqueous solution (pH 4.5) (bottom) and in 
the presence of E .coli LPS (0.05 mg/mL)(top). Line-broadening effect (R2) of TB_KKG6A in the 
presence of LPS indicates that the peptide binds to the LPS. 
 
  
Figure 2: Titration of E. coli LPS into TB_KKG6A followed by fluorescence. E .coli LPS (5 M) 
was titrated into a TB_ KKG6A _NBD (0.5 M) up to a molar ration LPS/peptide 2:1.Deviations 
are not visible for some points since their magnitude is smaller than the circles reported for the 
experimental points. 
 
 
Figure 3: Titration of TB_KKG6A (2 mM) into LPS (50 M) at 37°C followed by  ITC. 
 
Figure 4: Left. Sausage representation of TB_KKG6A bound to E. coli LPS NMR ensemble of 
structures. Right. The side-chains orientation of a representative NMR structure of TB_KKG6A 
bound to E. coli LPS. 
 
Figure 5: Surface representation showing the electrostatic surface potentials of the peptide 
TB_KKG6A bound to E. coli LPS. The hydrophobic surfaces are colored in light gray, positively 
charged residues in blue.  
 
 
 
 
 
 
 
 
Figure 6: Mapping of paramagnetic probes induced resonance perturbation of TB_KKG6A in LPS. 
The yellow side-chains are located inside the LPS, as demonstrated by 16-DSA perturbation. Lys10 
has a double conformation as showed in the two selected conformers. 
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